Article

Quantitative Assessment of Immune Cells in the Injured Spinal Cord Tissue by Flow Cytometry: a Novel Use for a Cell Purification Method

Institute for Memory Impairments and Neurological Disorders, University of California, USA.
Journal of Visualized Experiments 04/2011; DOI: 10.3791/2698
Source: PubMed

ABSTRACT Detection of immune cells in the injured central nervous system (CNS) using morphological or histological techniques has not always provided true quantitative analysis of cellular inflammation. Flow cytometry is a quick alternative method to quantify immune cells in the injured brain or spinal cord tissue. Historically, flow cytometry has been used to quantify immune cells collected from blood or dissociated spleen or thymus, and only a few studies have attempted to quantify immune cells in the injured spinal cord by flow cytometry using fresh dissociated cord tissue. However, the dissociated spinal cord tissue is concentrated with myelin debris that can be mistaken for cells and reduce cell count reliability obtained by the flow cytometer. We have advanced a cell preparation method using the OptiPrep gradient system to effectively separate lipid/myelin debris from cells, providing sensitive and reliable quantifications of cellular inflammation in the injured spinal cord by flow cytometry. As described in our recent study (Beck & Nguyen et al., Brain. 2010 Feb; 133 (Pt 2): 433-47), the OptiPrep cell preparation had increased sensitivity to detect cellular inflammation in the injured spinal cord, with counts of specific cell types correlating with injury severity. Critically, novel usage of this method provided the first characterization of acute and chronic cellular inflammation after SCI to include a complete time course for polymorphonuclear leukocytes (PMNs, neutrophils), macrophages/microglia, and T-cells over a period ranging from 2 hours to 180 days post-injury (dpi), identifying a surprising novel second phase of cellular inflammation. Thorough characterization of cellular inflammation using this method may provide a better understanding of neuroinflammation in the injured CNS, and reveal an important multiphasic component of neuroinflammation that may be critical for the design and implementation of rational therapeutic treatment strategies, including both cell-based and pharmacological interventions for SCI.

Download full-text

Full-text

Available from: Hal Nguyen, Jul 07, 2015
0 Followers
 · 
107 Views
  • Source
    • "Immune Cells—Immune cells are involved in defensive mechanisms against foreign or infectious materials in the body system and are activated by SCI. The activation of immune cells, more specifically infiltrating immune cells, such as polymorphonuclear leukocytes (PMN, neutrophils), macrophages and T-cells, develop at least 2 hours after injury and last over 6 months (Beck et al., 2010; Esposito et al., 2010; Nguyen et al., 2011). Activated and infiltrating neutrophils release proinflammatory cytokines, chemokines and reactive oxygen species (ROS) that contribute to lipid peroxidation and breakdown of blood-brain barrier (BBB) following SCI (Bao et al., 2004; Taoka and Okajima, 2000), suggesting that oxidative stress produced as a consequence of SCI plays a role in the breakdown of the BBB followed by infiltration of neutrophils from blood near the injury site (Lin et al., 2007; Schnell et al., 1999). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the spinal cord, neuron and glial cells actively interact and contribute to neurofunction. Surprisingly, both cell types have similar receptors, transporters and ion channels and also produce similar neurotransmitters and cytokines. The neuroanatomical and neurochemical similarities work synergistically to maintain physiological homeostasis in the normal spinal cord. However, in trauma or disease states, spinal glia become activated, dorsal horn neurons become hyperexcitable contributing to sensitized neuronal-glial circuits. The maladaptive spinal circuits directly affect synaptic excitability, including activation of intracellular downstream cascades that result in enhanced evoked and spontaneous activity in dorsal horn neurons with the result that abnormal pain syndromes develop.
    Experimental Neurology 10/2011; 234(2):362-72. DOI:10.1016/j.expneurol.2011.10.010 · 4.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Traumatic injury to the central nervous system (CNS) triggers a robust inflammatory response that leads to axonal damage and secondary degeneration of spared tissue. In contrast, some immune responses have neuroprotective effects. However, detailed information regarding the dynamics of immune responses after traumatic CNS injury is still unavailable. In the present study, changes in the immune cells present in the injured brain, spleen, and cervical lymph nodes (CLNs), which are draining lymphatic organs from the CNS, were analyzed after controlled cortical impact (CCI) by flow cytometry and immunohistochemistry. The number of neutrophils and macrophages that infiltrated the injured brain immediately increased 1 d post-injury and declined rapidly thereafter. In the injured brain, resident microglia showed a bimodal increase during the first week and in the chronic phase (≥3 weeks) after injury. Increase in the Iba-1(+) microglia/macrophages was observed around the injured site. Morphologic analysis showed that Iba-1(+) cells were round at 1 week, whereas those at 3 weeks were more ramified. Furthermore, CD86(+)/CD11b(+) M1-like microglia increased at 4 weeks after CCI, whereas CD206(+)/CD11b(+) M2-like microglia increased at 1 week. These results suggest that different subsets of microglia increased in the acute and chronic phases after CCI. Dendritic cells and T cells increased transiently within 1 week in the injured brain. In the CLNs and the spleen, T cells showed dynamic changes after CCI. In particular, the alteration in the number of T cells in the CLNs showed a similar pattern, with a 1-week delay, to that of microglia in the injured brain. The data from this study provide useful information on the dynamics of immune cells in CNS injuries.
    PLoS ONE 07/2012; 7(7):e41892. DOI:10.1371/journal.pone.0041892 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Allografts continue to be used in clinical neurotransplantation studies, hence it is crucial to understand the mechanisms that govern allograft tolerance. We investigated the impact of transplantation site within the brain on graft survival. Mouse (FVB) glial precursors, transfected with luciferase have been injected (3x10⁵) into the forceps minor (FM) or striatum (STR). Immunodeficient rag2-/- and immunocompetent BALB/c mice were used as recipients. Magnetic resonance imaging confirmed that cells were precisely deposited at the selected coordinates. The graft viability was assessed non-invasively with bioluminescent imaging for a period of 16 days. Regardless of implantation site all grafts (n=10) deposited in immunodeficient animals revealed excellent survival. In contrast, immunocompetent animals accepted all grafts only at STR site (n=10), while all FM grafts were rejected (n=10). To investigate the factors that led to rejection of FM grafts, with acceptance of STR grafts, another group of animals (n=19) was sacrificed during pre-rejection period, on day 5. Nearinfrared fluorescence imaging with IRDye®800CW-PEG probe displayed similar blood-brain barrier disruption at both graft locations. The morphological distribution of FM grafts was cylindrical, parallel to the needle track, while cells transplanted into the STR accumulated along the border between the striatum and corpus callosum. There was a significantly less infiltration by both innate and adaptive immune cells in the STR grafts, especially along the calloso-striatal border. With allograft survival being dependent on the transplantation site, the anatomical coordinates of the graft target should always be taken into account as it may determine success or failure of therapy.
    Cell Transplantation 01/2013; 23(2). DOI:10.3727/096368912X661328 · 3.57 Impact Factor